Employees: 11 (2023.0)Legal category: Société à responsabilité limitée (sans autre indication)Size: PMECreation date: 2011-04-28 (15 years)Status: ActiveBusiness sector: Commerce de détail de produits pharmaceutiques en magasin spécialiséLocation: CAUSSADE (82300), Tarn-et-Garonne
PHARMACIE LE GRAND - LAURENTIES : revenue, balance sheet and financial ratios
PHARMACIE LE GRAND - LAURENTIES is a French company
founded 15 years ago,
specialized in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé.
Based in CAUSSADE (82300),
this company of category PME
shows in 2022 a revenue of 4.2 M€.
Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.
Financial history - PHARMACIE LE GRAND - LAURENTIES (SIREN 531998797)
Indicator
2024
2023
2022
2021
2020
2019
2018
2017
2016
Revenue
N/C
N/C
4 154 843 €
3 937 410 €
3 907 825 €
3 764 437 €
3 777 926 €
3 636 682 €
3 687 644 €
Net income
26 730 €
90 635 €
139 695 €
123 931 €
65 728 €
43 767 €
103 504 €
82 721 €
178 801 €
EBITDA
N/C
N/C
208 510 €
204 072 €
129 236 €
152 945 €
174 503 €
190 556 €
331 687 €
Net margin
N/C
N/C
3.4%
3.1%
1.7%
1.2%
2.7%
2.3%
4.8%
Revenue and income statement
In 2024, PHARMACIE LE GRAND - LAURENTIES generates positive net income of 27 k€. Net income represents the final profit after all expenses (operating, financial, exceptional) and corporate tax. Change over 2016-2024: 179 k€ -> 27 k€.
Net income (2024)
?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax
26 730 €
Loading income statement...
Income statement
Item
Amount
% Revenue
Change
The detailed income statement is not available for this company (simplified accounts or confidential data).
Chart evolution
Show :
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Assets
Loading data...
Item
Gross
Deprec.
Net
%
Change
Assets balance sheet data not available for this company
Liabilities
Loading data...
Item
Year
%
Change
Liabilities balance sheet data not available for this company
Solvency and debt ratios
The debt ratio (= Financial debt / Equity x 100) stands at 122%. Debt level is high: negotiating margin with banks is reduced. Financial autonomy (= Equity / Total assets x 100) reaches 39%. The balance between equity and debt is satisfactory.
Debt ratio (2024)
?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low 50-100% : Moderate > 100% : High
122.117%
Financial autonomy (2024)
?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy 20-30% : Average < 20% : Low
39.167%
Asset age ratio (2024)
?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Solvency indicators evolution PHARMACIE LE GRAND - LAURENTIES
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Debt ratio
337.955
343.815
287.016
254.669
229.974
190.612
155.703
131.934
122.117
Financial autonomy
20.204
19.591
23.171
24.727
26.791
30.247
33.976
36.662
39.167
Repayment capacity
12.291
27.413
19.868
25.996
27.304
14.3
12.946
None
None
Cash flow / Revenue
5.751%
2.945%
3.662%
2.606%
2.3%
4.032%
3.852%
None%
None%
Sector positioning
Debt ratio
122.122024
2022
2023
2024
Q1: 16.46
Med: 58.47
Q3: 154.89
Average
In 2024, the debt ratio of PHARMACIE LE GRAND - LAUR... (122.12) ranks above the median of the sector. This ratio measures the weight of debt relative to equity. A reduction effort could improve financial strength.
Financial autonomy
39.17%2024
2022
2023
2024
Q1: 28.91%
Med: 49.95%
Q3: 69.47%
Average
In 2024, the financial autonomy of PHARMACIE LE GRAND - LAUR... (39.2%) ranks below the median of the sector. This ratio represents the share of equity in total financing. An improvement would strengthen the competitive position.
Repayment capacity
12.95 years2022
2022
Q1: 1.29 years
Med: 3.55 years
Q3: 6.63 years
Average
In 2022, the repayment capacity of PHARMACIE LE GRAND - LAUR... (12.95) ranks above the median of the sector. This ratio indicates the number of years needed to repay debt with cash flow. A reduction effort could improve financial strength.
Liquidity ratios
The liquidity ratio (= Current assets / Current liabilities) stands at 90.62. Concretely, the company has €2 of liquid assets for every €1 of short-term debt: no cash risk within 12 months.
Liquidity ratio (2024)
?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good 1-1.5 : Fair < 1 : Liquidity risk
90.621
Liquidity indicators evolution PHARMACIE LE GRAND - LAURENTIES
Visualisation créée via abddaf.fr Sources : INPI & BCE - Retraitements : Ministère de l'économie
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Liquidity ratio
132.205
166.224
174.627
143.782
150.831
146.729
125.803
113.73
90.621
Interest coverage
15.314
24.823
8.997
11.642
11.625
5.964
5.148
None
None
Sector positioning
Liquidity ratio
90.622024
2022
2023
2024
Q1: 129.47
Med: 182.13
Q3: 260.78
Watch
In 2024, the liquidity ratio of PHARMACIE LE GRAND - LAUR... (90.62) ranks in the bottom 25% of the sector. This ratio measures the ability to cover short-term debt with current assets. A ratio below 1 may signal potential cash flow tensions.
Interest coverage
5.15x2022
2022
Q1: 0.74x
Med: 2.5x
Q3: 5.15x
Excellent
In 2022, the interest coverage of PHARMACIE LE GRAND - LAUR... (5.2x) ranks in the top 25% of the sector. This ratio indicates how many times operating income covers interest expenses. High coverage means financial charges weigh little on profitability.
Working capital requirement (WCR) and payment terms
Working capital requirement (WCR) measures the cash timing gap between customer collections and supplier/inventory payments.
Operating WCR (2024)
?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released Positive = financing needed
0 €
Customer credit (2024)
?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good 45-60j : Average > 60j : Long
0 j
Supplier credit (2024)
?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow
0 j
Inventory turnover (2024)
?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover
0 j
WCR and payment terms evolution PHARMACIE LE GRAND - LAURENTIES
Visualization created via numbers.finance Sources : INPI & BCE - Adjustments : Ministry of Economy
Indicator
2016
2017
2018
2019
2020
2021
2022
2023
2024
Operating WCR
349 662 €
605 544 €
554 335 €
507 446 €
459 717 €
383 504 €
425 830 €
0 €
0 €
Inventory turnover (days)
36
47
49
43
40
33
34
0
0
Customer payment term (days)
5
7
4
6
4
4
3
0
0
Supplier payment term (days)
42
55
39
46
40
43
44
0
0
Positioning of PHARMACIE LE GRAND - LAURENTIES in its sector
Comparison with sector Commerce de détail de produits pharmaceutiques en magasin spécialisé
Valuation estimate
Based on 225 transactions of similar company sales
in 2024,
the value of PHARMACIE LE GRAND - LAURENTIES is estimated at
373 170 €
(range 259 870€ - 558 284€).
This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Estimated enterprise value2024
225 transactions
259k€373k€558k€
373 170 €Range: 259 870€ - 558 284€
NAF 5 année 2024
Valuation method used
Net Income Multiple
26 730 €
×
14.0x
=373 171 €
Range: 259 870€ - 558 285€
Only this financial indicator is available for this company.
Valuation evolution
Visualisation creee via abddaf.fr Sources : BODACC & INPI
How is this estimate calculated?
This estimate is based on the analysis of 225 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.
EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
Net Income Multiple: Relevant for mature companies with stable results.
This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).
Similar companies (Commerce de détail de produits pharmaceutiques en magasin spécialisé)
Compare PHARMACIE LE GRAND - LAURENTIES with other companies in the same sector:
Frequently asked questions about PHARMACIE LE GRAND - LAURENTIES
What is the revenue of PHARMACIE LE GRAND - LAURENTIES ?
The revenue of PHARMACIE LE GRAND - LAURENTIES in 2022 is 4.2 M€.
Is PHARMACIE LE GRAND - LAURENTIES profitable?
Yes, PHARMACIE LE GRAND - LAURENTIES generated a net profit of 27 k€ in 2024.
Where is the headquarters of PHARMACIE LE GRAND - LAURENTIES ?
The headquarters of PHARMACIE LE GRAND - LAURENTIES is located in CAUSSADE (82300), in the department Tarn-et-Garonne.
Where to find the tax return of PHARMACIE LE GRAND - LAURENTIES ?
The tax return of PHARMACIE LE GRAND - LAURENTIES is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).
In which sector does PHARMACIE LE GRAND - LAURENTIES operate?
PHARMACIE LE GRAND - LAURENTIES operates in the sector Commerce de détail de produits pharmaceutiques en magasin spécialisé (NAF code 47.73Z). See the 'Sector positioning' section above to compare the company with its competitors.
Item evolution
Rotate your phone to landscape mode to view the chart